Natural history of intramedullary spinal cord ependymoma in patients preferring nonoperative treatment
Surgical resection of intramedullary spinal cord ependymoma still remains the standard of care but is challenging and occasionally associated with poor outcome. The aim of this study is therefore to provide additional information regarding the natural history of conservatively treated symptomatic intramedullary spinal cord ependymoma. Retrospective, single center review of all patients with intramedullary spinal cord ependymoma treated conservatively (wait and see) between 1980 and 2016. The neurological outcomes at first presentation, as well as in long-term follow-up, were assessed using the modified McCormick Disability Scale and modified Rankin Scale. Thirteen of 41 patients were managed conservatively and were included in the study. Mean age at the admission was 49 years. There were seven women and six men. All patients were symptomatic at the time of presentation. The mean follow-up from admission to the last neurological examination was 47.9 months. The mean modified McCormick score in conservatively treated patients was 1.3 at admission and 1.6 (p = 0.3) at last follow-up. There was no significant neurological detoriation over time in conservatively managed patients as assessed by the modified Rankin Scale at first presentation and last follow-up (mRS scores of 0–2, 100 vs 92%; p = 0.9). This cohort of conservatively managed patients with symptomatic intramedullary spinal cord ependymoma was clinically stable throughout the follow-up period. Our data provide additional information for counseling patients with intramedullary spinal cord tumors who chose a nonoperative treatment.
KeywordsIntramedullary spinal cord ependymoma Surgery Conservative therapy Neurological status Follow-up Outcome
No funding supported this research.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 3.Aghakhani N, David P, Parker F, Lacroix C, Benoudiba F, Tadie M (2008) Intramedullary spinal ependymomas: analysis of a consecutive series of 82 adult cases with particular attention to patients with no preoperative neurological deficit. Neurosurgery 62:1279-85-6. doi: 10.1227/01.neu.0000333299.26566.15 Google Scholar
- 7.Karikari IO, Nimjee SM, Hodges TR, Cutrell E, Hughes BD, Powers CJ, et al (2011) Impact of tumor histology on resectability and neurological outcome in primary intramedullary spinal cord tumors: a single-center experience with 102 patients. Neurosurgery 68:188–197. doi: 10.1227/NEU.0b013e3181fe3794. (discussion 197)CrossRefPubMedGoogle Scholar
- 15.Raco A, Esposito V, Lenzi J, Piccirilli M, Delfini R, Cantore G (2005) Long-term follow-up of intramedullary spinal cord tumors: a series of 202 cases. Neurosurgery 56:972-81-81Google Scholar
- 17.Behmanesh B, Gessler F, Quick-Weller J, Spyrantis A, Imöhl L, Seifert V, et al (2017) Regional spinal cord atrophy is associated with poor outcome after surgery on intramedullary spinal cord ependymoma: a new aspect of delayed neurological deterioration. World Neurosurg. doi: 10.1016/j.wneu.2017.01.026.Google Scholar
- 22.Lee S-H, Chung CK, Kim CH, Yoon SH, Hyun S-J, Kim K-J et al (2013) Long-term outcomes of surgical resection with or without adjuvant radiation therapy for treatment of spinal ependymoma: a retrospective multicenter study by the Korea Spinal Oncology Research Group. Neuro-Oncology 15:921–929. doi: 10.1093/neuonc/not038 CrossRefPubMedPubMedCentralGoogle Scholar